Since the early 1980s, when interest in IGF1R’s role in breast cancer development began [3, 4], preclinical studies demonstrated that IGF1R is involved in cell transformation in addition to mediating tumor-promoting functions such as proliferation, antiapoptosis and cancer cell dissemination [5–7]. This evidence concerns the gene IGF1R and neoplasm.